SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$72.26
Tradestie Score
62
Market Cap
$994.20M
Analyst Upside
+24.7%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$59.84
|
$6.68B | - | 55 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$81.99
|
$6.64B | - | 59 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$108.32
|
$6.38B | - | 53 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$23.25
|
$6.03B | - | 59 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$51.68
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$100.10
|
$5.95B | - | 55 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$183.48
|
$5.92B | - | 64 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$33.36
|
$5.80B | 12.8 | 60 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$261.17
|
$5.20B | 39.8 | 67 | Compare |
More SYRE Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry